ARID5B and acute lymphoblastic leukemia: In summary, our observations in 72 BCP-ALL cell lines suggest that the risk allele of the relapse-linked SNPs of ARID5B may be associated with higher relapse rates because of resistance to chemotherapeutic agents such as VCR, CY, and AraC.